CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals

Neutral
AI Analysis

Summary

Johnson & Johnson issued upbeat guidance but saw stock dip; AstraZeneca and Spero Therapeutics cut their China deals.

Financial Highlights

Guidance

upbeat

Importance:3/10
Sentiment:
0.20
China operationsdeal cutsportfolio changes
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 9:18 AM

Read Original